JP2024527340A5 - - Google Patents
Info
- Publication number
- JP2024527340A5 JP2024527340A5 JP2023581043A JP2023581043A JP2024527340A5 JP 2024527340 A5 JP2024527340 A5 JP 2024527340A5 JP 2023581043 A JP2023581043 A JP 2023581043A JP 2023581043 A JP2023581043 A JP 2023581043A JP 2024527340 A5 JP2024527340 A5 JP 2024527340A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- present
- amount ranging
- casein
- chitosan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163202970P | 2021-07-01 | 2021-07-01 | |
| US63/202,970 | 2021-07-01 | ||
| PCT/US2022/035870 WO2023278802A1 (en) | 2021-07-01 | 2022-06-30 | Formulations for oral delivery of nucleic acids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527340A JP2024527340A (ja) | 2024-07-24 |
| JP2024527340A5 true JP2024527340A5 (cg-RX-API-DMAC7.html) | 2025-07-07 |
Family
ID=84690648
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023581003A Pending JP2024525512A (ja) | 2021-07-01 | 2022-06-30 | 治療用核酸及びその使用方法 |
| JP2023581043A Pending JP2024527340A (ja) | 2021-07-01 | 2022-06-30 | 核酸の経口送達用の製剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023581003A Pending JP2024525512A (ja) | 2021-07-01 | 2022-06-30 | 治療用核酸及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20240285668A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4363434A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2024525512A (cg-RX-API-DMAC7.html) |
| KR (2) | KR20240028486A (cg-RX-API-DMAC7.html) |
| CN (2) | CN117897162A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2022303330A1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3223495A1 (cg-RX-API-DMAC7.html) |
| WO (2) | WO2023278802A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3563859B1 (en) | 2012-08-13 | 2021-10-13 | Cedars-Sinai Medical Center | Cardiosphere-derived exosomes for tissue regeneration |
| CA2962444C (en) | 2014-10-03 | 2023-09-05 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy |
| EP3749344A4 (en) | 2018-02-05 | 2022-01-26 | Cedars-Sinai Medical Center | METHODS OF THERAPEUTIC USE OF EXOSOMES AND Y-RNAS |
| KR20250078993A (ko) * | 2022-09-30 | 2025-06-04 | 세다르스-신나이 메디칼 센터 | 치료용 핵산 및 그의 사용 방법 |
| KR20260074974A (ko) * | 2023-09-15 | 2026-05-27 | 세다르스-신나이 메디칼 센터 | 유전독성 스트레스를 약화시키고 심장 보호 효과를 발휘하는 trex-1 증강제 |
| WO2026035943A1 (en) | 2024-08-08 | 2026-02-12 | Cedars-Sinai Medical Center | Formulations for oral delivery of nucleic acids |
| WO2026035744A1 (en) | 2024-08-08 | 2026-02-12 | Cedars-Sinai Medical Center | Combination therapies for metabolic disease |
| KR20260065643A (ko) * | 2024-10-31 | 2026-05-11 | 성균관대학교산학협력단 | CU-rich RNA를 포함하는 근위축증 또는 근육 손상의 예방 또는 치료용 조성물 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7780873B2 (en) * | 2004-02-23 | 2010-08-24 | Texas A&M University System | Bioactive complexes compositions and methods of use thereof |
| DK2182969T3 (en) * | 2007-07-31 | 2017-02-27 | Univ Texas | Micro-RNA family that modulates fibrosis and its applications |
| CN102639700A (zh) * | 2009-09-30 | 2012-08-15 | 哈佛大学校长及研究员协会 | 通过调节自噬增强基因产物调节自噬的方法 |
| US10258698B2 (en) * | 2013-03-14 | 2019-04-16 | Modernatx, Inc. | Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions |
| US20160024575A1 (en) * | 2013-05-02 | 2016-01-28 | The Regents Of The University Of California | Circulating small noncoding rna markers |
| WO2015055857A1 (en) * | 2013-10-18 | 2015-04-23 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Rny-derived small rnas as biomarkers for atherosclerosis-related disorders |
| CA2962444C (en) * | 2014-10-03 | 2023-09-05 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy |
| HK1249108A1 (zh) * | 2015-01-20 | 2018-10-26 | 米拉根医疗股份有限公司 | Mir-92抑制剂及其用途 |
| WO2017136652A1 (en) * | 2016-02-04 | 2017-08-10 | Tarveda Therapeutics, Inc. | Stapled peptide conjugates and particles |
| WO2017193051A1 (en) * | 2016-05-06 | 2017-11-09 | The Trustees Of Princeton University | Methods of monitoring rnase l activity |
| CN111448317B (zh) * | 2017-12-22 | 2025-07-04 | 罗氏创新中心哥本哈根有限公司 | 包含二硫代磷酸酯核苷间键的缺口聚物寡核苷酸 |
| EP3749344A4 (en) * | 2018-02-05 | 2022-01-26 | Cedars-Sinai Medical Center | METHODS OF THERAPEUTIC USE OF EXOSOMES AND Y-RNAS |
| US12258594B2 (en) * | 2018-12-05 | 2025-03-25 | The Broad Institute, Inc. | Cas proteins with reduced immunogenicity and methods of screening thereof |
| WO2020131986A1 (en) * | 2018-12-21 | 2020-06-25 | Pioneer Hi-Bred International, Inc. | Multiplex genome targeting |
| WO2026035744A1 (en) * | 2024-08-08 | 2026-02-12 | Cedars-Sinai Medical Center | Combination therapies for metabolic disease |
| WO2026035943A1 (en) * | 2024-08-08 | 2026-02-12 | Cedars-Sinai Medical Center | Formulations for oral delivery of nucleic acids |
-
2022
- 2022-06-30 KR KR1020247003755A patent/KR20240028486A/ko active Pending
- 2022-06-30 JP JP2023581003A patent/JP2024525512A/ja active Pending
- 2022-06-30 AU AU2022303330A patent/AU2022303330A1/en active Pending
- 2022-06-30 KR KR1020247003744A patent/KR20240027814A/ko active Pending
- 2022-06-30 WO PCT/US2022/035870 patent/WO2023278802A1/en not_active Ceased
- 2022-06-30 JP JP2023581043A patent/JP2024527340A/ja active Pending
- 2022-06-30 US US18/572,067 patent/US20240285668A1/en active Pending
- 2022-06-30 AU AU2022303384A patent/AU2022303384A1/en active Pending
- 2022-06-30 CN CN202280059718.0A patent/CN117897162A/zh active Pending
- 2022-06-30 WO PCT/US2022/035866 patent/WO2023278799A1/en not_active Ceased
- 2022-06-30 US US18/571,924 patent/US20250025487A1/en active Pending
- 2022-06-30 CN CN202280059708.7A patent/CN117916249A/zh active Pending
- 2022-06-30 EP EP22834283.8A patent/EP4363434A4/en active Pending
- 2022-06-30 CA CA3223495A patent/CA3223495A1/en active Pending
- 2022-06-30 EP EP22834280.4A patent/EP4362954A4/en active Pending
- 2022-06-30 CA CA3223686A patent/CA3223686A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023138984A (ja) | Vegf-aポリペプチドをコードする改変rnaを送達するための脂質ナノ粒子 | |
| JP3566283B2 (ja) | 心臓疾患の予防又は治療用の医薬組成物 | |
| DE60219611T2 (de) | Modifizierte annexin-proteine und verhinderung und behandlung von thrombose | |
| CN113993526B (zh) | 包含源自牛奶的外泌体作为有效成分的用于治疗代谢性疾病的药物组合物 | |
| US20160250290A1 (en) | Gene therapy for diabetic ischemic disease | |
| US20240285668A1 (en) | Formulations for oral delivery of nucleic acids | |
| JP2024525512A5 (cg-RX-API-DMAC7.html) | ||
| WO1997044056A1 (en) | Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma | |
| WO2023231730A2 (zh) | 使用mazdutide的治疗方法 | |
| Hemachudha et al. | Letter to the Editor Paralytic complications following intravenous rabies immune globulin treatment in a patient with furious rabies | |
| EP4716698A1 (en) | Treatment of multiple sclerosis with anti-cd40l antibodies | |
| JP2026063281A (ja) | 薬物動態及び/又は安全性に優れるテリパラチド含有液状医薬組成物 | |
| US11987645B2 (en) | Peptide for treating rheumatoid arthritis and use thereof | |
| US20220226243A1 (en) | Methods of using lipid nanoparticles for delivering modified rna encoding a vegf-a polypeptide and pharmaceutical compositions comprising the same | |
| AU747885B2 (en) | Treatment of disease states | |
| EP4041281B1 (en) | Use of gdf15 for treating cardiometabolic syndrome and other conditions | |
| RU2032422C1 (ru) | Способ лечения инфаркта миокарда | |
| JP2023538984A5 (cg-RX-API-DMAC7.html) | ||
| CN103013902B (zh) | 产降钙素基因相关肽与犬钩虫抗凝肽AcAP5融合蛋白基因工程菌株及其构建方法 | |
| HERRON et al. | The Use of Autolyzed Liver in the Treatment of Pernicious Anemia: A Preliminary Clinical Report | |
| TWI309570B (cg-RX-API-DMAC7.html) | ||
| Lee et al. | Chronic mucocutaneous candidiasis with candida granuloma treated with 5-fluorocytosine | |
| WO2025208818A1 (zh) | 治疗下肢外周动脉疾病的核酸分子、药物组合物及其应用 | |
| JP2025512987A5 (cg-RX-API-DMAC7.html) | ||
| MXPA98009760A (en) | Therapeutic uses of bpi protein products in human beings with bleeding due to tra |